Patents by Inventor David W. Thrower

David W. Thrower has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10328067
    Abstract: An apparatus and method for formulating low solubility, low permeability and/or p-glycoprotein efflux transporter substrate drugs or herbal extracts for increased intestinal absorption. The method utilizes a supercritical fluid, such as carbon dioxide to complex a low solubility, low permeability and/or p-glycoprotein efflux transporter substrate drug or herbal extract, the p-glycoprotein inhibitors quercitin and piperine, with a carbohydrate. The result is a micro-emulsion of the drug or herbal extract which has both higher solubility and permeability than if dosed alone; as well as resistance to p-glycoprotein mediated efflux, once absorbed into the intestinal lumen.
    Type: Grant
    Filed: August 21, 2017
    Date of Patent: June 25, 2019
    Inventor: David W. Thrower
  • Publication number: 20180071214
    Abstract: A method of formulating low solubility, low permeability and/or p-glycoprotein efflux transporter substrate drugs or herbal extracts for increased intestinal absorption and a composition of matter for said drugs or herbal extracts. The method utilizes a water, alcohol or organic solvent to complex a low solubility, low permeability and/or p-glycoprotein efflux transporter substrate drug or herbal extract, the p-glycoprotein inhibitors quercitin and piperine, with a carbohydrate. The result is a microemulsion of the drug or herbal extract which has both higher solubility and permeability than if dosed alone; as well as resistance to p-glycoprotein mediated efflux, once absorbed into the intestinal lumen.
    Type: Application
    Filed: September 4, 2017
    Publication date: March 15, 2018
    Inventor: David W. Thrower
  • Publication number: 20180055829
    Abstract: An apparatus and method for formulating low solubility, low permeability and/or p-glycoprotein efflux transporter substrate drugs or herbal extracts for increased intestinal absorption. The method utilizes a supercritical fluid, such as carbon dioxide to complex a low solubility, low permeability and/or p-glycoprotein efflux transporter substrate drug or herbal extract, the p-glycoprotein inhibitors quercitin and piperine, with a carbohydrate. The result is a micro-emulsion of the drug or herbal extract which has both higher solubility and permeability than if dosed alone; as well as resistance to p-glycoprotein mediated efflux, once absorbed into the intestinal lumen.
    Type: Application
    Filed: August 21, 2017
    Publication date: March 1, 2018
    Inventor: David W. Thrower